December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.

December 15, 2008 - The FDA has approved Abbott's TRILIPIX (fenofibric acid) delayed-release capsules, the first and only fibrate indicated for use in combination with a statin for cholesterol management.

The drug is indicated for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. In certain patients, treatment guidelines recommend the combination of a fibrate with a statin to further improve lipid levels. TRILIPIX has not been shown to prevent heart disease or heart attack.

December 16, 2008 - New data from a retrospective, multicenter, cohort study of over four million hospitalized patients shows similar unadjusted mortality rates for patients receiving DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.

Study findings were published in the December 2008 issue of The American Journal of Cardiology.

December 16, 2008 – Digisonics was awarded the Best in KLAS for the cardiology market segment in the 2008 Top 20 Best in KLAS Awards report published this week.

The KLAS evaluation is comprised of 40 individual questions that cover everything from contracting and sales to implementation, service and upgrades.

December 15, 2008 - Lantheus Medical Imaging reported that new data from a retrospective, multicenter, cohort study of over four million hospitalized patients showed similar unadjusted mortality rates for patients receiving DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.

December 15, 2008 - Visage Imaging Inc. has received FDA 510(k) clearance to market its latest thin-client product release, Visage CS 3.1, which boasts significant enhancements to its prior offerings in cardiac and other tools, and includes new optional applications for neurology and oncology.

The neuro option facilitates brain perfusion analysis in CT and MRI imaging, while the oncology option provides tools for analyzing, documenting, and comparing lesions for multiple modalities, including Standardized Update Value (SUV)-based analysis for PET-CT.

December 15, 2008 - Boston Scientific Corp. today announced FDA approval of its Express SD Renal Monorail Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries.

The Express SD System is the first low-profile, pre-mounted stent approved for use in renal arteries in the U.S., and is the only FDA-approved renal stent designed to provide additional proximal end support, says Boston Scientific.

December 15, 2008 - Terumo Corp. and its subsidiary, Terumo Cardiovascular Systems Corp., announced they have entered into an agreement to settle all outstanding litigation with Maquet Cardiovascular LLC.

The companies have a number of lawsuits pending in which each claims the other has infringed its patents. The litigations all involve methods and devices used in endoscopic vessel harvesting. All pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license certain patents.

December 15, 2008 - In regions of the country where cardiologists perform high numbers of cardiac catheterizations to diagnose heart problems, patients may be receiving percutaneous cardiac interventions (PCI) more than they need or want, according to a study published online last week in the journal Circulation.

December 15, 2008 - Two additional hospitals in the U.S. opened patient enrollment for CardioVascular BioTherapuetics Inc.’s ACORD Phase II clinical trial for the treatment of severe coronary heart disease.
The sites are Minneapolis Heart Institute Foundation in Minneapolis MN, and Princeton Baptist Medical Center in Birmingham, AL.
Mercy Hospital Fairfield (Ohio) and The Christ Hospital in Cincinnati, OH were first to open for enrollment in early September, and are working in collaboration to screen and treat patients in the trial.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now